Statistics
Publications
10
Citations
400
H-Index
10
Active since
1998
Thomas Pangerl is an author at University of Vienna specializing in oncology, medicine, and molecular oncology.
Publications per year
1998–2010
10
10
Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829.
Irene Virgolini, M. Leimer, Hirsch Handmaker et al. · PubMed · 1998 · 108 citations
Medicine, Oncology, Pharmacology +15
DOTA-Lanreotide: A Novel Somatostatin Analog for Tumor Diagnosis and Therapy1
Peter Smith‐Jones, Claudia Bischof, M. Leimer et al. · Endocrinology · 1999 · 84 citations · Full text
Medicine, Oncology, Pharmacology +16
New trends in peptide receptor radioligands.
Irene Virgolini, C. Novotny, M. Leimer et al. · PubMed · 2001 · 45 citations
111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung.
Ventzislav Petkov, Sedat Ofluoglu, Thomas Pangerl et al. · PubMed · 2001 · 34 citations
Medicine, Nuclear Medicine, Oncology +17
1–5 of 10